Cargando…
Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells
Cancer therapy is limited by toxicity in normal cells and drug-resistance in cancer cells. Paradoxically, cancer resistance to certain therapies can be exploited for protection of normal cells, simultaneously enabling the selective killing of resistant cancer cells by using antagonistic drug combina...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010629/ https://www.ncbi.nlm.nih.gov/pubmed/36913303 http://dx.doi.org/10.18632/oncotarget.28382 |